Novel 2,5-dideoxystreptamine derivatives targeting the ribosomal decoding site RNA

Bioorganic and Medicinal Chemistry Letters

Volumn 12, Issue 23, 2002, Pages 3367-3372

  Vourloumis, Dionisios ^a   Takahashi, Masayuki ^a   Winters, Geoffrey C ^a   Simonsen, Klaus B ^a   Ayida, Benjamin K ^a   Barluenga, Sofia ^a   Qamar, Seema ^a   Shandrick, Sarah ^a   Zhao, Qiang ^a   Hermann, Thomas ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

2,5 DIDEOXYSTREPTAMINE DERIVATIVE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; RIBOSOME RNA; UNCLASSIFIED DRUG; AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; HEXOSAMINE; LUCIFERASE;

ANTIMICROBIAL ACTIVITY; ARTICLE; CATALYSIS; DEPROTECTION REACTION; DRUG TARGETING; HYDROGENATION; NONHUMAN; X RAY CRYSTALLOGRAPHY; BINDING SITE; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; GENETIC TRANSCRIPTION; GENETICS; METABOLISM; PROTEIN SYNTHESIS; STRUCTURE ACTIVITY RELATION;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; BINDING SITES; HEXOSAMINES; LUCIFERASES; MODELS, MOLECULAR; PROTEIN BIOSYNTHESIS; RNA, RIBOSOMAL; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC;

EID: 17444444927     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)00759-X     Document Type: Article

References (48)

1. (a) Moazed D., Noller H.F. Nature. 327:1987;389
2. (b) Woodcock J., Moazed D., Cannon M., Davies J., Noller H.F. EMBO J. 10:1991;3099
3. (c) Purohit P., Stern S. Nature. 370:1994;659.
4. (a) Carter A.P., Clemons W.M., Brodersen D.E., Morgan-Warren R.J., Wimberly B.T., Ramakrishnan V. Nature. 407:2000;340
5. (b) Brodersen D.E., Clemons W.M., Carter A.P., Morgan-Warren R.J., Wimberly B.T., Ramakrishnan V. Cell. 103:2000;1143
6. (c) Ogle J.M., Bordersen D.E., Clemons W.M., Tarry M.J., Carter A.P., Ramakrishnan V. Science. 292:2001;897.
7. Wright, G. D.; Berghuis, A. M.; Mobashery, S. In Resolving the Antibiotic Paradox: Progress in Understanding Drug Resistance and Development of New Antibiotics; Rosen, B. P., Mobashery, S., Eds; Plenum: New York, 1998; p 27, and references cited therein.
8. (a) Ramakrishnan V. Cell. 108:2002;557
9. (b) Schroeder R., Waldsich C., Wank H. EMBO J. 19:2000;1.
10. Wong C.-H., Hendrix M., Priestley E.S., Greenberg W.A. Chem. Biol. 5:1998;397.
11. (a) Recht M.I., Fourmy D., Blanchard S.C., Dahlquist K.D., Puglisi J.D. J. Mol. Biol. 262:1996;421
12. (b) Fourmy D., Recht M.I., Blanchard S.C., Puglisi J.D. Science. 274:1996;1367
13. (c) Fourmy D., Yoshizawa S., Puglisi J.D. J. Mol. Biol. 277:1998;333
14. (d) Fourmy D., Recht M.I., Puglisi J.D. J. Mol. Biol. 277:1998;347.
15. Vicens Q., Westhof E. Structure. 9:2001;647.
16. Ma C., Baker N.A., Joseph S., McCammon J.A. J. Am. Chem. Soc. 124:2002;1438.
17. Alper P., Hendrix M., Sears P., Wong C.-H. J. Am. Chem. Soc. 120:1998;1965.
18. Greenberg W.A., Priestley E.S., Sears P.S., Alper P.B., Rosenbohm C., Hendrix M., Hung S.-C., Wong C.-H. J. Am. Chem. Soc. 121:1999;6527.
19. Hanessian S., Tremblay M., Kornienko A., Moitessier N. Tetrahedron. 57:2001;3255.
20. Haddad J., Kotra L.P., Llano-Sotelo B., Kim C., Azucena E.F., Liu M., Vakulenko S.B., Chow C.S., Mobashery S. J. Am. Chem. Soc. 124:2002;3229.
21. (a) Hermann T. Angew. Chem. 39:2000;1890
22. (b) Hermann T., Westhof E. Comb. Chem. High Throughput Screen. 3:2000;219
23. (c) Gallego J., Varani G. Acc. Chem. Res. 34:2001;836.
24. Kotra L.P., Haddad J., Mobashery S. Antimicrob. Agents Chemother. 44:2000;3249.
25. (a) Tor Y., Hermann T., Westhof E. Chem. Biol. 5:1998;R277
26. (b) Michael K., Tor Y. Chem. Eur. J. 4:1998;2091
27. (c) Hermann T., Westhof E. Biopolym. Nucl. Acid Sci. 48:1999;155
28. (d) Suchek S.J., Shue Y.-K. Curr. Opin. Drug Discov. Develop. 4:2001;462.
29. (a) Park W.K., Auer M., Jaksche H., Wong C.-H. J. Am. Chem. Soc. 118:1996;10150
30. (b) Nunns C.L., Spence L.A., Slater M.J., Berrisford D. J. Tetrahedron Lett. 40:1999;9341.
31. Simonsen, K. B. Ayida, B.; Vourloumis, D.; Takahashi, M.; Winters, G. C.; Barluenga, S.; Qamar, S.; Shandrick, S.; Zhao, Q.; Hermann, T. ChemBioChem. In press.
32. Wuonola, M. A.; Powers D. G. In Use of Combinatorial Libraries in the Discovery of Novel Antiinfectives; Chaiken, I. M., Janda K. D., Eds.; American Chemical Society: Washington, DC, 1996; p 284.
33. Ding Y., Hofstadler S.A., Swayze E.E., Griffey R.H. Org. Lett. 3:2001;1621.
34. Kurisu T., Yamashita M., Nishimura Y., Miyake T., Tsuchiya T., Umezawa S. Bull. Chem. Soc. Jpn. 49:1976;285.
35. Georgiadis M.P., Constantinou-Kokotou V. J. Carbohydr. Chem. 10:1991;739.
36. 2 and high-resolution crystal structures of a synthetic 35 nt RNA construct containing the bacterial decoding site internal loop (Q. Zhao, Q. Han, T. Hermann, unpublished). The conformational space available to the 6′-hydroxyl group of paromamine docked to the decoding site RNA was explored using Insight/Discover (Accelrys) and the AMBER force field following established protocols: Hermann T., Westhof E. J. Med. Chem. 42:1999;1250.
37. Cavender C.J., Shiner V.J. J. Org. Chem. 37:1972;3567.
38. Alper P.B., Hung S.-C., Wong C.-H. Tetrahedron Lett. 37:1996;6029.
39. Nakajima N., Horita K., Abe R., Yonemitsu O. Tetrahedron Lett. 29:1988;4139.
40. Binkley R.W., Ambrose M.G., Hehemann D.G. J. Org. Chem. 45:1980;4387.
41. Soli E.D., Manoso A.S., Patterson M.C., DeShong P. J. Org. Chem. 64:1999;3171.
42. Lipshutz B.H., Wilhelm R.S., Kozlowski J.A., Parker D. J. Org. Chem. 49:1984;3928.
43. 3) δ 191.7, 155.6, 155.6, 148.0, 140.0, 137.2, 136.2, 136.1, 128.4 (3C), 128.0 (6C), 75.1, 71.8, 66.9, 55.5, 50.3, 44.8, 32.6.
44. Suami T., Nishiyama S., Isikawa Y., Katsura S. Carbohydr. Res. 53:1997;239.
45. 6 sulfoxide) δ 167.7, 156.6, 156.3, 139.3, 139.0, 138.2, 138.1, 134.7, 129.3, 129.2, 129.1, 128.7, 128.6, 128.6, 128.5, 128.4, 128.4, 77.2, 71.6, 66.2, 66.0, 51.5, 47.3, 31.3.
46. For amines 16c and 16i the final hydrogenation step resulted in cleavage of the furane or partial reduction of the pyrazine ring, respectively, leading to the formation of products 17c and 17i.
47. Zhang J.-H., Chung T.D.Y., Oldenburg K.R. J. Biomol. Screening. 2:1999;67.
48. 3, (M+H): 243.2, found 243.2.